HPCSA issues guidance on Telemedicine Guidelines application during pandemic

Acknowledging that medical practitioners are faced with an ethical dilemma of how to contribute to the national endeavours of self-isolation and social distancing and continue...

Mitigating loneliness, anxiety in seniors

It is important clinicians pay close attention to the mental health of all patients, but particularly the elderly, with the restrictions being imposed to curb the spread...

COVID-19: Stopgap measure to treat respiratory distress

Researchers at MIT and the University of Colorado at Denver have proposed a stopgap measure that they believe could help Covid-19 patients who are...

Critical Care, Anaesthesiologists issue joint COVID-19 statement

The Critical Care Society of Southern Africa (CCSSA) and the South African Society of Anaesthesiologists (SASA) issued the following joint statement last night: The CCCSA...

Article addresses management of cancer care during COVID-19

Management of cancer care during the COVID-19 pandemic is addressed in a special feature article published online in the Journal of the National Comprehensive Cancer...

Cumulative dose of oral steroids associated with hypertension Incidence

For adults with any of six chronic inflammatory diseases, a cumulative dose of oral glucocorticoids is associated with an increased incidence of hypertension, according...

Guidance issued for prenatal care in COVID-19 setting

In new guidelines specific to maternal-fetal medicine practitioners, published online in the American Journal of Obstetrics & Gynecology MFM, recommendations are presented for prenatal care in the setting...

SAHPRA warns against stockpiling meds including chloroquine

The South African Health Products Regulatory Agency (SAHPRA) has cautioned against medicine stockpiling including chloroquine-containing products.  In addition to licensing medicines that are safe, effective and of...

MPS issues guidance on remote consultation during COVID-19 pandemic

The current situation surrounding the COVID-19 coronavirus has created a number of challenges, many of which relate to self-isolation and social distancing. For doctors,...

Medical sector cooperative developing niche products for shareholders

 MediCoop is developing investment, finance and insurance solutions specific for health professionals’ individual and business circumstances. MediCoop’s members are also shareholders.  Medicoop investment services MediCoop’s savings products...

Despite FWA Summit postponement, Section 59 report still to be released...

In its statement announcing the postponement of the Fraud, Waste and Abuse (FWA) Summit from 2 to 3 April in Durban to a date...

COVID-19 challenge no time for corporate profits: SECTION27

The Treatment Action Campaign had to litigate against pharmaceutical companies back in 2001 to drop the price of medicines to treat HIV: "We do...

Africa Health moved from May to October

After consultation with partners from around the world, the organisers of the annual Africa Health Exposition and Conference have decided to postpone this year’s...

SAMA calls for telemedicine regulations to be relaxed in COVID-19 fight

The South African Medical Association (SAMA) says it supports the measures announced by President Cyril Ramaphosa 15 March to contain the spread of coronavirus...

Germ destroying robots strengthening hospital infection prevention and control

With the increase in the spread of the novel coronavirus in South Africa, there has been a surge of interest among the public regarding...

ACEIs and ARBs may increase risk of severe COVID-19

The SARS beta coronaviruses, SARS-CoV, which caused the SARS (Severe Acute Respiratory Syndrome) outbreak in 2003 and the new SARS-CoV-2, which causes COVID-19, bind...

Austell donates chloroquine tablets to SA in fight against COVID-19*

Austell Pharmaceuticals has announced that it will be donating 500 000 chloroquine phosphate tablets to the South African government in its fight against the...

Therapeutic options for COVID-19 patients: CDC

There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19.  At present clinical management includes infection...